Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Cost-Cutting Successes Spark Productivity Strategy Changes

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble Co. ramps up its productivity efforts with the addition of a global officer of productivity and organization transformation. The firm says it is on track to achieve cost-cutting goals stated in an initiative it announced in February 2012.

You may also be interested in...



P&G Shareholders Push For More Power Over Board Membership

With more power to shake up P&G’s board, shareholders could ultimately have a greater hand in changes to company management. Activist investor William Ackman – whose firm Pershing Square Capital owns roughly a 1% stake in the firm – is rumored to be pushing to replace P&G CEO Bob McDonald.

DHS Guidance Smooths Potential Wrinkles In US Supplement Industry Being ‘Essential’ Nationwide

VMS businesses are deemed essential in Department of Homeland Security guidance that provides as basis for orders by most states and localities across the US. During an AHPA webinar, attorney Trent Norris says the federal government prefers leaving business exemptions to shut-down decisions to the states.

Light At End of Tunnel As Some Conferences Reschedule, But Lights Off For Others In 2020

CHPA’s Regulatory, Scientific & Quality Conference rescheduled for 1-2 September and the Dietary Supplements Regulatory Summit for 16 September. Several spring conferences canceled due to Covid-19 will not be rescheduled, groups say.

Topics

Related Companies

UsernamePublicRestriction

Register

PS106057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel